F. H. Barnett
Author pages are created from data sourced from our academic publisher partnerships and public sources.
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
- M. Dorrell, E. Aguilar, L. Scheppke, F. H. Barnett, M. Friedlander
- Medicine, Biology
- Proceedings of the National Academy of Sciences
- 16 January 2007
Angiostatic therapies designed to inhibit neovascularization associated with multiple pathological conditions have only been partially successful; complete inhibition has not been achieved. We… Expand
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
A second-generation replication-conditional herpes simplex virus type 1 (HSV) vector defective for both ribonucleotide reductase (RR) and the neurovirulence factor gamma34.5 was generated and tested… Expand
Macrophages form functional vascular mimicry channels in vivo
- F. H. Barnett, M. Rosenfeld, +5 authors M. Friedlander
- Medicine, Chemistry
- Scientific reports
- 11 November 2016
Macrophages, key cells of the innate immune system, are known to support angiogenesis but are not believed to directly form vessel walls. Here we show that macrophages structurally form primitive,… Expand
Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
Brain tumors that have disseminated into cerebrospinal fluid (CSF) pathways are an unresolved therapeutic problem, especially in pediatric neurooncology. Here a gene therapy approach using the herpes… Expand
Spontaneous rapid resolution of an epidural hematoma associated with an overlying skull fracture and subgaleal hematoma in a 17-month-old child.
Acute traumatic epidural hematomas (EDH) constitute one of the most critical emergencies in neurosurgical management. The rapid spontaneous resolution (<24 h) of EDH is an extremely rare phenomenon.… Expand
Gene Therapy for Brain Tumors
Gene therapy has opened new doors for treatment of neoplastic diseases. This new approach seems very attractive, especially for glioblastomas, since treatment of these brain tumors has failed using… Expand
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.
This study investigated the intraarterial delivery of genetically engineered replication-deficient adenovirus vectors (AVs) and cationic liposome-plasmid DNA complexes (lipoDNA) to experimental brain… Expand
Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7
RMP-7, a bradykinin analog, has been shown to selectively open the blood-tumor barrier for the delivery of chemotherapeutic drugs to brain tumors. In contrast to bradykinin, RMP-7 has no hypotensive… Expand
Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure
- F. H. Barnett, M. Scharer-Schuksz, M. Wood, X. Yu, T. Wagner, M. Friedlander
- Gene Therapy
- 1 August 2004
Glioblastoma multiforme (GBM) is an incurable malignant brain tumor, usually fatal within 1 year of diagnosis. Using a syngeneic rat 9L gliosarcoma model, we have developed a novel drug delivery… Expand